These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 29212455)

  • 21. NHERF1 Suppresses Lung Cancer Cell Migration by Regulation of Epithelial-Mesenchymal Transition.
    Yang F; Gu Y; Zhao Z; Huang J; Jiang WG; Cheng S
    Anticancer Res; 2017 Aug; 37(8):4405-4414. PubMed ID: 28739734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120).
    Huang RY; Kuay KT; Tan TZ; Asad M; Tang HM; Ng AH; Ye J; Chung VY; Thiery JP
    Oncotarget; 2015 Sep; 6(26):22098-113. PubMed ID: 26061747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of SATB2 is critical for induction of epithelial-to-mesenchymal transition and invasion of NSCLC cells.
    Kucuksayan H; Ozes ON; Akca H
    Lung Cancer; 2016 Aug; 98():122-129. PubMed ID: 27393518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
    Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
    Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of DIP2C in RKO cells stimulates changes in DNA methylation and epithelial-mesenchymal transition.
    Larsson C; Ali MA; Pandzic T; Lindroth AM; He L; Sjöblom T
    BMC Cancer; 2017 Jul; 17(1):487. PubMed ID: 28716088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foxk2 inhibits non-small cell lung cancer epithelial-mesenchymal transition and proliferation through the repression of different key target genes.
    Chen S; Jiang S; Hu F; Xu Y; Wang T; Mei Q
    Oncol Rep; 2017 Apr; 37(4):2335-2347. PubMed ID: 28260088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
    Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Network biology approach to epithelial-mesenchymal transition in cancer metastasis: three stage theory.
    Tanaka H; Ogishima S
    J Mol Cell Biol; 2015 Jun; 7(3):253-66. PubMed ID: 26103982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
    Mittal V
    Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 17 gene panel for non-small-cell lung cancer prognosis identified through integrative epigenomic-transcriptomic analyses of hypoxia-induced epithelial-mesenchymal transition.
    Chen YL; Zhang Y; Wang J; Chen N; Fang W; Zhong J; Liu Y; Qin R; Yu X; Sun Z; Gao F
    Mol Oncol; 2019 Jul; 13(7):1490-1502. PubMed ID: 30973670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.
    Fujiwara A; Shintani Y; Funaki S; Kawamura T; Kimura T; Minami M; Okumura M
    Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel network profiling analysis reveals system changes in epithelial-mesenchymal transition.
    Shimamura T; Imoto S; Shimada Y; Hosono Y; Niida A; Nagasaki M; Yamaguchi R; Takahashi T; Miyano S
    PLoS One; 2011; 6(6):e20804. PubMed ID: 21687740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.
    Jin Y; Li F; Zheng C; Wang Y; Fang Z; Guo C; Wang X; Liu H; Deng L; Li C; Wang H; Chen H; Feng Y; Ji H
    Int J Cancer; 2014 May; 134(10):2294-304. PubMed ID: 24174333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An individualized transcriptional signature to predict the epithelial-mesenchymal transition based on relative expression ordering.
    Chen T; Zhao Z; Chen B; Wang Y; Yang F; Wang C; Dong Q; Liu Y; Liang H; Zhao W; Qi L; Xu Y; Gu Y
    Aging (Albany NY); 2020 Jul; 12(13):13172-13186. PubMed ID: 32639951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of epithelial-mesenchymal transition-related genes increases with copy number in multiple cancer types.
    Zhao M; Liu Y; Qu H
    Oncotarget; 2016 Apr; 7(17):24688-99. PubMed ID: 27029057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.
    Suda K; Tomizawa K; Fujii M; Murakami H; Osada H; Maehara Y; Yatabe Y; Sekido Y; Mitsudomi T
    J Thorac Oncol; 2011 Jul; 6(7):1152-61. PubMed ID: 21597390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.